NDNina A. Daha

Nina A. Daha

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nina A. Daha has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Risk stratification and characterisation of subpopulations of frail elderly in the primary care practice using routine healthcare data

    by Nina Daha, Johan Immerzeel, Ida Spelt, Margot De Waal, Monica Van Eijck, Mattijs Numans, Marc Bruijnzeels

    Background: A major challenge in primary health care today, is the increase of frail elderly individuals in primary care practices. The current reactive approach leads to a rise of unplanned visits to the emergency room and after hours general practitioners consultations. The aim of the current study is to identify and characterise subpopulations of community dwelling elderly as a lead towards a 'needs-tailored' and pro-active care approach. Methods: This is a retrospective cohort study of 9668 patients with a follow up of 1 year median age: 67 years [interquartile range, 64-74]; 5128 women [53%]. The patients were community dwelling elderly, registered in the general practitioner registration network in the western part of The Netherlands. A frailty index FI score, based on the International Classification of Primary Care ICPC and medication use ATC, was calculated for each patient. This was defined as the proportion of deficits from a predefined and validated list of 50 deficits drubbel et al. 2013. Based on this FI score, five subgroups were formed and characterised on coded diagnosis and symptoms, medication use and social vulnerability as coded in the routine data by the general practitioner. Results: The median FI score of the total study population was 0.16 interquartile range 0.1-0.24. The quintile of the population with the highest FI scores median 0.32 [0.28-0.62] contained more woman 64% and a higher median age 75 [60-101]. Further characterisation of the subpopulations showed a difference in overall prevalence of deficits, while the distribution of the most prominent deficits does not greatly differ between subpopulations. Both social vulnerability and polypharmacy were highly prevalent in the subpopulation with the highest FI scores 98.8% vs 6.2% and 27% vs 5.2% respectively. Conclusion: By using primary care routine health data, we can identify subpopulations of frail community dwelling elderly and show differences in the characteristics of these populations. These differences are of importance as a lead towards a more targeted, integrated healthcare approach, which is aimed at the needs of the different subpopulations. Limitations: Misclassification due to missing data is a risk of the current approach using routine healthcare data. Therefore it is of importance for further research to investigate the needs of the identified subpopulations by qualitative research designs. Daha; Risk stratification and characterisation of subpopulations of frail elderly in the primary care practice using routine healthcare data

  • Open Access

    A genetic variant in osteoprotegerin is associated with progression of joint destruction in rheumatoid arthritis

    by Rachel Knevel, Diederik Pc de Rooy, Tore Saxne, Elisabet Lindqvist, Martha K Leijsma, Nina A Daha, Bobby Pc Koeleman, Roula Tsonaka, Jeanine J Houwing-Duistermaat, Joris Jm Schonkeren, et al.

    Introduction: Progression of joint destruction in rheumatoid arthritis (RA) is partly heritably; 45 to 58% of the variance in joint destruction is estimated to be explained by genetic factors. The binding of RANKL (Receptor Activator for Nuclear Factor κ B Ligand) to RANK results in the activation of TRAF6 (tumor necrosis factor (TNF) receptor associated factor-6), and osteoclast formation ultimately leading to enhanced bone resorption. This bone resorption is inhibited by osteoprotegerin (OPG) which prevents RANKL-RANK interactions. The OPG/RANK/RANKL/TRAF6 pathway plays an important role in bone remodeling. Therefore, we investigated whether genetic variants in OPG, RANK, RANKL and TRAF6 are associated with the rate of joint destruction in RA. Methods: 1,418 patients with 4,885 X-rays of hands and feet derived from four independent data-sets were studied. In each data-set the relative increase of the progression rate per year in the presence of a genotype was assessed. First, explorative analyses were performed on 600 RA-patients from Leiden. 109 SNPs, tagging OPG, RANK, RANKL and TRAF6, were tested. Single nucleotide polymorphisms (SNPs) significantly associated in phase-1 were genotyped in data-sets from Groningen (Netherlands), Sheffield (United Kingdom) and Lund (Switzerland). Data were summarized in an inverse weighted variance meta-analysis. Bonferonni correction for multiple testing was applied. Results: We found that 33 SNPs were significantly associated with the rate of joint destruction in phase-1. In phase-2, six SNPs in OPG and four SNPs in RANK were associated with progression of joint destruction with P-value OPG-rs1485305 expressed higher rates of joint destruction compared to patients without these risk variants (P = 2.35x10−4). This variant was also significant after Bonferroni correction. Conclusions: These results indicate that a genetic variant in OPG is associated with a more severe rate of joint destruction in RA.


  • Novel genetic association of the VTCN1 region with rheumatoid arthritis

    by Nina A Daha, Benedicte A Lie, L A Trouw, Gerrie Stoeken, Joris J M Schonkeren, Bo Ding, Tore K Kvien, Marco W Schilham, Leonid Padyukov, T W J Huizinga, et al.

    Objective Based upon findings in juvenile idiopathic arthritis, the genetic contribution of the VTCN1 region to rheumatoid arthritis (RA) susceptibility and anticitrullinated protein antibody (ACPA) status was investigated. VTCN1 is known to play a pivotal role in regulation of the immune system and, in soluble form, has previously been associated with higher disease activity. Methods Ten VTCN1 polymorphisms were genotyped in 1237 Dutch patients with RA and 1055 healthy controls. Significant findings were replicated in two independent RA populations of northern European descent consisting of 2826 patients and 2122 healthy controls. Allele distribution was analysed using a χ2 test and combined analysis of all studies was performed using the Mantel–Haenszel fixed effects method. Results A significant association with two polymorphisms was observed in the Dutch RA population. Replication of these findings showed an overall significant association with rs4376721 and rs10923217 (OR 1.13, 95% CI 1.03 to 1.24, p=0.013 and OR 0.78, 95% CI 0.67 to 0.91, p=0.0011, respectively). Stratification for ACPA status revealed an association in the ACPA-negative subset for rs4376721 (OR 1.19, 95% CI 1.05 to 1.35, p=0.0071), while no overall significance could be observed in the ACPA-positive population. rs10923217 was associated with both subsets of the disease. Conclusion These results indicate a novel genetic association with the VTCN1 region in RA susceptibility.


  • Are ACPA-positive and ACPA-negative RA the same disease?

    by Nina A. Daha, Rene E. M. Toes

    Seemingly contrasting genetic backgrounds in anti-citrullinated-protein antibody (ACPA)-positive and ACPA-negative rheumatoid arthritis (RA) support the notion that these are in fact two distinct disease subsets, with different underlying pathogenesis, that might need tailored treatment strategies.